Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,769 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes.
Perkins J, Field T, Kim J, Kharfan-Dabaja MA, Ayala E, Perez L, Fernandez H, Fancher K, Tate C, Shaw LM, Milone MC, Gardiner JA, Miller S, Anasetti C. Perkins J, et al. Bone Marrow Transplant. 2011 Nov;46(11):1418-25. doi: 10.1038/bmt.2010.315. Epub 2010 Dec 6. Bone Marrow Transplant. 2011. PMID: 21132026
Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
Ballester OF, Agaliotis DP, Hiemenz JW, Janssen WE, Fields KK, Zorksy PE, Goldstein SC, Perkins JB, Elfenbein GJ. Ballester OF, et al. Among authors: perkins jb. Bone Marrow Transplant. 1996 Jul;18(1):9-14. Bone Marrow Transplant. 1996. PMID: 8831989 Clinical Trial.
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.
Ballester OF, Tummala R, Janssen WE, Fields KK, Hiemenz JW, Goldstein SC, Perkins JB, Sullivan DM, Rosen R, Sackstein R, Zorsky P, Saez R, Elfenbein GJ. Ballester OF, et al. Among authors: perkins jb. Bone Marrow Transplant. 1997 Oct;20(8):653-6. doi: 10.1038/sj.bmt.1700950. Bone Marrow Transplant. 1997. PMID: 9383228 Clinical Trial.
Are matched unrelated donor transplants justified for AML in CR1?
Anasetti C, Perkins J, Nieder ML, Field T. Anasetti C, et al. Among authors: perkins j. Best Pract Res Clin Haematol. 2006;19(2):321-8. doi: 10.1016/j.beha.2005.12.002. Best Pract Res Clin Haematol. 2006. PMID: 16516129 Review.
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation.
Field T, Perkins J, Huang Y, Kharfan-Dabaja MA, Alsina M, Ayala E, Fernandez HF, Janssen W, Lancet J, Perez L, Sullivan D, List A, Anasetti C. Field T, et al. Among authors: perkins j. Bone Marrow Transplant. 2010 Feb;45(2):255-60. doi: 10.1038/bmt.2009.134. Epub 2009 Jun 22. Bone Marrow Transplant. 2010. PMID: 19543327
Infliximab for managing steroid-refractory acute graft-versus-host disease.
Pidala J, Kim J, Field T, McBride A, Kharfan-Dabaja M, Perkins J, Fernandez H, Perez L, Ayala E, Anasetti C. Pidala J, et al. Among authors: perkins j. Biol Blood Marrow Transplant. 2009 Sep;15(9):1116-21. doi: 10.1016/j.bbmt.2009.05.019. Biol Blood Marrow Transplant. 2009. PMID: 19660725 Free article.
1,769 results